Table 1 Baseline characteristics of trial participants
Intervention arm | Standard Care arm | All participants | |
|---|---|---|---|
Socio demographic | N=126 | N=85 | N=211 |
% male (N) | 61.9% (78) | 70.6% (60) | 65.4% (138) |
Age (years) | 62.5 (11.0) | 64.1 (10.3) | 63.2 (10.7) |
IMD Deprivation rank (0-100) | 10.2 (6.4) | 10.4 (6.8) | 10.3 (6.8) |
Health-related | |||
SF12 Physical [3] (norm 50 | 43.3 (11.2) | 45.5 (10.3) | 44.2 (10.9) |
range 0-100) | |||
SF12 Mental [3] (norm 50 | 48.0 (10.6) | 50.0 (9.6) | 48.8 (10.2) |
range 0-100) | |||
Duration of diabetes (years) | 6.7 (4.8) | 6.9 (5.3) | 6.8 (5.0) |
Weight (kg) | 97.4 (21.7) | 94.5 (19.6) | 96.2 (20.9) |
Systolic blood pressure (mmHg) | 137.4 (16.2) | 136.2 (15.9) | 136.9 (16.0) |
Diastolic blood pressure (mmHg) | 78.3 (8.9) | 78.1 (9.1) | 78.2 (9.0) |
HbA1c (%) [1] | 8.37 (1.25) | 8.28 (1.22) | 8.33 (1.24) |
HbA1c (mmol/mol) | 68.0 (2.7 | 67.0 (2.4) | 67.5 (2.6) |
Medication-related | |||
% treated with metformin (N) [4] | 86.7% (104) | 87.9% (73) | 87.2% (177) |
Metformin daily dose (mg) * [4] | 1450 (795) | 1525 (780) | 1480 (788) |
Total number of medications taken/day | 5.7 (2.4) | 5.9 (2.6) | 5.8 (2.5) |
Adherence (MARS) [2] (range 5-25) | 23.6 (2.3) | 23.6 (2.8) | 23.6 (2.5) |